Total Payments
$323.13
2022 Payments
$96.59
Companies
4
Transactions
16
Medicare Patients
5,057
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$323.13 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $323.13 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orthogenrx Inc. | $139.10 | 9 | $0 (2021) |
| DePuy Synthes Sales Inc. | $87.44 | 2 | $0 (2017) |
| Avanos Medical | $56.35 | 3 | $0 (2022) |
| Bioventus LLC | $40.24 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $96.59 | 5 | Avanos Medical ($56.35) |
| 2021 | $33.21 | 2 | Orthogenrx Inc. ($33.21) |
| 2020 | $28.34 | 2 | Orthogenrx Inc. ($28.34) |
| 2019 | $16.74 | 1 | Orthogenrx Inc. ($16.74) |
| 2018 | $28.23 | 2 | Orthogenrx Inc. ($28.23) |
| 2017 | $120.02 | 4 | DePuy Synthes Sales Inc. ($87.44) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2022 | Avanos Medical | TRIVISC SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/02/2022 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Not Applicable | ||||||
| 04/27/2022 | Avanos Medical | GENVISC 850 SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/19/2022 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Not Applicable | ||||||
| 03/21/2022 | Avanos Medical | GENVISC 850 SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/22/2021 | Orthogenrx Inc. | TriVisc sodium hyaluronate (Device), GenVisc 850 sodium hyaluronate | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Osteoarthritis | ||||||
| 05/27/2021 | Orthogenrx Inc. | TriVisc sodium hyaluronate (Device), GenVisc 850 sodium hyaluronate | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Osteoarthritis | ||||||
| 10/07/2020 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Osteoarthritis | ||||||
| 07/07/2020 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Osteoarthritis | ||||||
| 04/16/2019 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Osteoarthritis | ||||||
| 10/16/2018 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Osteoarthritis | ||||||
| 04/30/2018 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Osteoarthritis | ||||||
| 11/15/2017 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Osteoarthritis | ||||||
| 09/29/2017 | Orthogenrx Inc. | GenVisc 850 (Device) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Osteoarthritis | ||||||
| 04/29/2017 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $39.91 | General |
| Category: Sports Early Intervention | ||||||
| 04/28/2017 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $47.53 | General |
| Category: Sports Early Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 728 | 27,440 | $668,194 | $293,099 |
| 2022 | 11 | 1,172 | 30,166 | $742,727 | $495,182 |
| 2021 | 16 | 1,447 | 32,868 | $798,865 | $610,477 |
| 2020 | 17 | 1,710 | 36,999 | $869,849 | $641,579 |
Total Patients
5,057
Total Services
127,473
Medicare Billing
$2.0M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 118 | 23,725 | $419,767 | $126,973 | 30.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 130 | 999 | $110,396 | $84,757 | 76.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 130 | 1,023 | $78,721 | $51,168 | 65.0% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2023 | 17 | 1,300 | $24,856 | $9,314 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 86 | $8,875 | $5,599 | 63.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $8,285 | $5,022 | 60.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 60 | $3,512 | $2,457 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $3,143 | $2,342 | 74.5% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 67 | 107 | $3,752 | $2,249 | 59.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,808 | $2,235 | 46.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $1,179 | $675.12 | 57.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 12 | $900.25 | $307.96 | 34.2% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 117 | 17,676 | $310,719 | $226,625 | 72.9% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2022 | 91 | 9,650 | $184,508 | $90,726 | 49.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 189 | 1,002 | $110,606 | $85,834 | 77.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 189 | 1,104 | $80,751 | $54,399 | 67.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 192 | 192 | $22,763 | $14,904 | 65.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 142 | $11,943 | $8,605 | 72.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 115 | 146 | $7,808 | $5,705 | 73.1% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 124 | 192 | $7,132 | $4,134 | 58.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $3,650 | $2,650 | 72.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 18 | 18 | $1,625 | $899.03 | 55.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 24 | 24 | $1,222 | $700.13 | 57.3% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2021 | 179 | 29,525 | $505,183 | $399,355 | 79.1% |
| 77002 | Fluoroscopic guidance for insertion of needle | Office | 2021 | 180 | 1,093 | $120,259 | $95,249 | 79.2% |
About Dr. Anthony Sancetta, DO
Dr. Anthony Sancetta, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043218233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Sancetta, DO has received a total of $323.13 in payments from pharmaceutical and medical device companies, with $96.59 received in 2022. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($323.13).
As a Medicare-enrolled provider, Sancetta has provided services to 5,057 Medicare beneficiaries, totaling 127,473 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Location Ocala, FL
- Active Since 07/12/2005
- Last Updated 09/29/2011
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1043218233
Products in Payments
- GenVisc 850 (Device) $105.89
- ORTHOVISC (Device) $87.44
- GELSYN-3 (Device) $40.24
- GENVISC 850 SODIUM HYALURONATE (Device) $34.85
- TriVisc sodium hyaluronate (Device) $33.21
- TRIVISC SODIUM HYALURONATE (Device) $21.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.